# Saposhnikovia divaricata Inhibits Inflammation, Oxidative Stress, and Ferroptosis to Alleviate DSS-Induced Ulcerative Colitis

**Authors:** Lin Liu, Qiting Dou, Xiaoxuan Zhao, Yun Liang, Ziyi Tian, Dantong Su, Lin Zhou, Xuguang Hu

PMC · DOI: 10.3390/antiox15020258 · Antioxidants · 2026-02-18

## TL;DR

Saposhnikovia divaricata reduces inflammation and oxidative stress in ulcerative colitis by inhibiting ferroptosis through the p53 signaling pathway.

## Contribution

This study reveals a novel mechanism by which Saposhnikovia divaricata alleviates UC through inhibition of ferroptosis.

## Key findings

- FF reduced inflammation and oxidative stress in LPS-induced macrophage cells.
- FF ameliorated DSS-induced UC symptoms in mice by modulating ferroptosis markers.
- FF regulated p53 signaling by down-regulating p53 and up-regulating SLC7A11 and GPX4.

## Abstract

Ulcerative colitis (UC) is a chronic inflammatory bowel disease that seriously jeopardizes health. Saposhnikovia divaricata (FF) has anti-inflammatory and antioxidant pharmacological effects. Numerous studies have demonstrated the efficacy of FF in alleviating UC, but the potential mechanism by which inhibiting ferroptosis alleviates UC remains unclear. This research aims to investigate the ways in which FF regulates inflammation, oxidative stress and ferroptosis to attenuate UC. Firstly, the chemical compounds of FF were identified by UPLC-Q-Orbitrap HRMS. FF significantly reduced levels of nitric oxide (NO), proinflammatory cytokines and reactive oxygen species (ROS) in the lipopolysaccharide (LPS)-induced inflammation in RAW264.7 macrophage cells. We used 3% Dextrose sulfate sodium (DSS) to establish the UC model in C57BL/6 mice. FF (8.4 g/kg) effectively ameliorated the symptoms of weight loss and colon damage, significantly attenuating oxidative stress and modulated the levels of ferroptosis markers in the colon. Moreover, FF can down-regulate the expression of p53 protein and up-regulate the expression of SLC7A11 and GPX4 proteins. The results showed that FF can inhibit inflammation, oxidative stress, and ferroptosis to alleviate DSS-induced UC, by regulating the p53 signaling pathway.

## Linked entities

- **Genes:** TP53 (tumor protein p53) [NCBI Gene 7157], SLC7A11 (solute carrier family 7 member 11) [NCBI Gene 23657], GPX4 (glutathione peroxidase 4) [NCBI Gene 2879]
- **Proteins:** TP53 (tumor protein p53), SLC7A11 (solute carrier family 7 member 11), GPX4 (glutathione peroxidase 4)
- **Chemicals:** nitric oxide (PubChem CID 145068)
- **Diseases:** ulcerative colitis (MONDO:0005101)

## Full-text entities

- **Genes:** Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Trp53-ps (transformation related protein 53, pseudogene) [NCBI Gene 22060], TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, Pik3r1 (phosphoinositide-3-kinase regulatory subunit 1) [NCBI Gene 18708] {aka PI3K, p50alpha, p55alpha, p85alpha}, Slc7a11 (solute carrier family 7 (cationic amino acid transporter, y+ system), member 11) [NCBI Gene 26570] {aka 9930009M05Rik, sut, xCT}, p53-ps (Wistar clone pR53P1 p53 pseudogene) [NCBI Gene 301300], Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, Gpx4 (glutathione peroxidase 4) [NCBI Gene 29328] {aka Gshpx-4, Phgpx, gpx-4, snGpx}, SLC7A11 (solute carrier family 7 member 11) [NCBI Gene 23657] {aka CCBR1, xCT}, Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}, Slc7a11 (solute carrier family 7 member 11) [NCBI Gene 310392], GPX4 (glutathione peroxidase 4) [NCBI Gene 2879] {aka GPx-4, GSHPx-4, MCSP, PHGPx, SMDS, snGPx}, Akt1 (Akt serine/threonine kinase 1) [NCBI Gene 11651] {aka Akt, LTR-akt, PKB, PKB/Akt, PKBalpha, Rac}, Gpx4 (glutathione peroxidase 4) [NCBI Gene 625249] {aka GPx-4, GSHPx-4, PHGPx, mtPHGPx, snGPx}, Trp53 (transformation related protein 53) [NCBI Gene 22059] {aka Tp53, bbl, bfy, bhy, p44, p53}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}
- **Diseases:** neurological reactions (MESH:D009461), diarrhea (MESH:D003967), obesity (MESH:D009765), edema (MESH:D004487), abdominal pain (MESH:D015746), tumor (MESH:D009369), diabetes mellitus (MESH:D003920), hematoma (MESH:D006406), Inflammation (MESH:D007249), gastrointestinal symptoms (MESH:D012817), injury to (MESH:D014947), UC (MESH:D003093), Colon Injury (MESH:D003108), necrosis (MESH:D009336), intestinal diseases (MESH:D007410), IBD (MESH:D015212), osteoporosis (MESH:D010024), ulcer (MESH:D014456), cytotoxicity (MESH:D064420), weight loss (MESH:D015431), macrophage (MESH:D055501), colitis (MESH:D003092), peptic ulcers (MESH:D010437), bone marrow suppression (MESH:D001855), gastrointestinal disturbances (MESH:D005767), infections (MESH:D007239), colorectal cancer (MESH:D015179), immunodeficiency (MESH:D007153), hypertension (MESH:D006973), dysentery (MESH:D004403)
- **Chemicals:** aldehydes (MESH:D000447), NO (MESH:D009569), ethanol (MESH:D000431), Imperatorin (MESH:C031534), iron (MESH:D007501), DCFH-DA (MESH:C029569), Water (MESH:D014867), phospholipid (MESH:D010743), Prim-O-glucosylcimifugin (MESH:C498945), LPO (MESH:D008054), streptomycin (MESH:D013307), acetonitrile (MESH:C032159), oxygen (MESH:D010100), DHE (MESH:C067883), formic acid (MESH:C030544), ME (MESH:D019804), methanol (MESH:D000432), Pinobanksin (MESH:C108261), Paraffin (MESH:D010232), ROS (MESH:D017382), flavonoids (MESH:D005419), glucose (MESH:D005947), Isoimperatorin (MESH:C055542), coumarins (MESH:D003374), 3,3'-diaminobenzidine (MESH:D015100), eosin (MESH:D004801), paraformaldehyde (MESH:C003043), lipid (MESH:D008055), LPS (MESH:D008070), GSH (MESH:D005978), CO2 (MESH:D002245), DSS (MESH:D016264), AP (MESH:D000667), MDA (MESH:D008315), Decursin (MESH:C101278), chromones (MESH:D002867), propolis (MESH:D011429), hematoxylin (MESH:D006416), cystine (MESH:D003553), penicillin (MESH:D010406), polyunsaturated fatty acids (MESH:D005231), H&amp;E (MESH:D006371), Aminosalicylates (MESH:D010131), superoxide (MESH:D013481), Chinese herbal medicines (-)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], gut metagenome (species) [taxon 749906], Saposhnikovia divaricata (species) [taxon 203717], Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116]
- **Mutations:** D1206D
- **Cell lines:** RAW264.7 — Mus musculus (Mouse), Mouse leukemia, Cancer cell line (CVCL_0493), CCK-8 — Homo sapiens (Human), T-cell prolymphocytic leukemia, Cancer cell line (CVCL_5443), C57BL/6 — Mus musculus (Mouse), Transformed cell line (CVCL_C0MU)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12938764/full.md

## Figures

11 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12938764/full.md

## References

86 references — full list in the complete paper: https://tomesphere.com/paper/PMC12938764/full.md

---
Source: https://tomesphere.com/paper/PMC12938764